16:35 EDT Salarius Pharmaceuticals trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLRX:
- Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
- Salarius receives FDA clearance for IND application of SP-3164 Phase 1 trial
- Salarius presents SP-3164 targeted protein degrader preclinical data
- Salarius Pharmaceuticals Presents SP-3164 Targeted Protein Degrader Preclinical Data at the European Hematology Association 2023 Hybrid Congress